-
January 1, 2014
Google Patents:Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies
-
December 31, 2013
Journal of Vascular Research:Beta-Amyloid Increases Metallo- and Cysteine Protease Activities in Human Macrophages Beta-Amyloid Increases Metallo- and Cysteine Protease Activities in Human Macrophages
-
December 29, 2013
Guardian Liberty Voice:Alzheimer's Affected by Cholesterol Level Alzheimer's Affected by Cholesterol Level
-
December 29, 2013
Mirror:Alzheimer's and dementia could be linked to high cholesterol and bad diet, study reveals Alzheimer's and dementia could be linked to high cholesterol and bad diet, study reveals
-
December 29, 2013
Medical Daily:Risk Of Alzheimer's Disease Doubles In Presence Of Specific Gene Variants, Motivating Early Treatment Risk Of Alzheimer's Disease Doubles In Presence Of Specific Gene Variants, Motivating Early Treatment
-
December 27, 2013
examiner.com:New study shows Concussions may be linked to Alzheimer's disease New study shows Concussions may be linked to Alzheimer's disease
-
December 26, 2013
ACS Publications:Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer's Disease Rational Design of a Structural Framework with Potential Use to Develop Chemical Reagents That Target and Modulate Multiple Facets of Alzheimer's Disease
-
December 25, 2013
MedPage Today:Head Trauma May Trigger Amyloid Buildup Head Trauma May Trigger Amyloid Buildup
-
December 24, 2013
The Almagest:High Blood Sugar Makes Alzheimer's Plaque More Toxic to the Brain High Blood Sugar Makes Alzheimer's Plaque More Toxic to the Brain
-
December 19, 2013
The Almagest:In elderly, hardening of arteries linked to plaques in brain In elderly, hardening of arteries linked to plaques in brain
-
December 17, 2013
BioMed Central:A central role for dityrosine crosslinking of Beta-Amyloid in Alzheimer's disease A central role for dityrosine crosslinking of Beta-Amyloid in Alzheimer's disease
-
December 16, 2013
PsychCentral:Mice Study Implicates Brain Vessel Damage in Alzheimer's Mice Study Implicates Brain Vessel Damage in Alzheimer's
-
December 15, 2013
Futurity:Damaged blood vessels may contribute to Alzheimer's Damaged blood vessels may contribute to Alzheimer's
-
December 15, 2013
Basque Research:Identified new genetic variants and new gene, the presence of which significantly increases risk of contracting Alzheimer's Identified new genetic variants and new gene, the presence of which significantly increases risk of contracting Alzheimer's
-
December 14, 2013
Medical Press:Uncovering first molecular missteps that drive neurons in pathway leading to Alzheimer's disease Uncovering first molecular missteps that drive neurons in pathway leading to Alzheimer's disease
-
December 12, 2013
Science Codex:Study breaks blood-brain barriers to understanding Alzheimer's Study breaks blood-brain barriers to understanding Alzheimer's
-
December 11, 2013
Google Patents:Methods of treating alzheimer's disease and other tauopathies with inhibitors of microtubule affinity regulating kinase Methods of treating alzheimer's disease and other tauopathies with inhibitors of microtubule affinity regulating kinase
-
December 10, 2013
Market Watch:Roche and Prothena Enter Into Worldwide Collaboration to Co-Develop and Co-Promote Antibodies for Treatment of Parkinson's Disease Roche and Prothena Enter Into Worldwide Collaboration to Co-Develop and Co-Promote Antibodies for Treatment of Parkinson's Disease
-
December 9, 2013
Ingenta Connect:Reduced Alzheimer's Disease Pathology by St. John's Wort Treatment is Independent of Hyperforin and Facilitated by ABCC1 and Microglia Activation in Mice Reduced Alzheimer's Disease Pathology by St. John's Wort Treatment is Independent of Hyperforin and Facilitated by ABCC1 and Microglia Activation in Mice
-
December 9, 2013
Reuters:Merck moves Alzheimer's drug into big trials after safety review Merck moves Alzheimer's drug into big trials after safety review